Key facts
- This page summarizes Frank E. Thomas's Form 4 filing for Orchard Therapeutics plc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Apr 2022, 16:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.758. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
SEC remarks
Title: President & Chief Operating Officer